Sygnus reports 36% increase in year end net profit

September 16, 2019

In United States dollars (except where it is indicated otherwise)

Sygnus Credit Investments Limited, for the nine months ended June 30, 2019 reported Interest Income of US$3.17 million 171% increase on the US$1.17 million recorded in 2018. For the quarter, Interest Income rose 104% to US$727,583 (2018: US$356,542).

The Company also reported Fair Value Gains of US$135,429 (2018: US$644,326) and Participation fees of US$50,944 (2018: US$23,413). Management noted the performance of Fair Value Gains, “reflected investments in two Portfolio Companies with profit sharing participation, in addition to regular investment income that is earned.” As such, Sygnus reported year end revenue of US$3.35 million compared to US$1.84 million. For the quarter, Sygnus booked revenue of US$645,412 versus US$878,337 for the quarter ended June 31, 2018.  Management highlighted, “SCI’s record results were driven by an expanding portfolio of private credit investments across the Caribbean region, in keeping with SCI’s mandate to provide Caribbean middle market firms with access to a non-traditional financing channel.”

Total Expenses for the year amounted to US$1.30 million, a 214% surge relative to US$414,909 recorded for the corresponding period in 2018. Total expenses for the quarter amounted to US$521,214 relative to US$206,474 for the same quarter of 2018. Of expenses:

    • Management fees amounted to US$707,175 (2018: US$182,368).
    • Other expenses for the period amounted to US$68,415 (2018: US$2,142). Audit Fees declined 25% year over year from US$48,435 in 2018 to US$36,537 for the year ended June 2019.
    • Registration fees decline 40% to US$9,310, down from US$15,581 in 2018. Directors Fees and Related Expenses rose 38% to close at $US40,203 (2018: US$29,225). Irrecoverable Withholding Tax and Professional Fees amounted to US$39,239 (2018: US$25,317) and US$60,609 (2018: US$32,572) respectively
    • Impairment Allowance on Financial Assets for the year amounted to US$74,645 versus nil for 2018. Management indicated, “the ECL for FYE Jun 2019 was US$74.78 thousand following the adoption of IFRS 9 at the beginning of the financial year. This represents 0.3% of the value of assets carried at amortized cost before the application of ECL. There was no comparable figure for FYE Jun 2018, as, under the ECL transition method chosen, comparative information for the similar period last year is not restated. SCI does not have any non-performing or impaired private credit investments.”

Profit for the year of  US$2.05 million was booked for 2019, relative to US$1.42 million in 2018, a 44% increase year over year. For the quarter the Company booked US$124,198 compared to US$671,863 for the same quarter of 2018.

As a result, Earnings per share (EPS) for the year amounted to US$0.0059 (2018: USD$0.0041). EPS for the quarter amounted to US$0.0004 (2018: US$0.0019). The number of shares used in our calculations amounted to 350,087,563 units. Notably, SCIJA and SCIJMD closed the trading period on September 16, 2019 at a price of $13.06 and $23.06 respectively. Both SCIUS and SCIUSD closed the trading period on September 16, 2019 at US$0.13 and US$0.15.

Management indicated, “SCI made new investment commitments valued at US$18.23 million during FYE Jun 2019 vs US$15.07 million in FYE Jun 2018, net of repayments. The number of Portfolio Companies expanded to 19 for FYE Jun 2019 vs 7 for FYE Jun 2018.”

 

Balance Sheet Highlights

As at September 16, 2019, Sygnus’ total assets amounted to US$38.15 million, a 3% increase on 2018’s assets base of US$37 million. This was due to an increase in ‘investments’ to US$32.39 million (2018: US$15.20 million) and ‘Finance lease receivables which was declared at US$1.58 million (2018: 498,960). Cash and Cash Equivalents jumped from US$400,259 as at June 30, 2019 to US$2.10 million as at June 30, 2019.

Total Stockholders’ equity as at June 30, 2019, closed at $37.59 million, relative to $36.62 million for the corresponding period last year. This resulted in a book value per share of US$0.11 compared to the value of $0.10 as June 30, 2018.

 

 

Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

 

 

 

More Stories from the Market
shutterstock_453968572
January 30, 2026   Caribbean Assurance Brokers Limited (CABROKERS) has advised that Ms. Donna Brown, who currently serves as Chief Operatin…
shutterstock_453968572
January 30, 2026   NCB Financial Group Limited (NCBFG) has advised that the Board of Directors is scheduled to meet on Thursday, February 1…
shutterstock_148562033
January 30, 2026   Image Plus Consultants Limited (IPCL) has advised that a connected party purchased a total of 11,000 IPCL shares during …
shutterstock_453968572
January 30, 2026   Kingston: Dolla Financial Services Limited (“DOLLA”), issuer of the invitation for subscription of its public Bond Offer…
shutterstock_453968572
January 29, 2026   Kintyre Holdings (JA) Limited (KNTYR) has advised that it has acquired additional shares in Kulcha Rum, increasing its o…
shutterstock_537598660
January 30, 2026 Indies Pharma Jamaica Limited (INDIES) Audited financials for the twelve months ended October 31, 2025 Indies Pharma Jamai…
Margin Loan Facility
Hambani Estates Reaches Key Construction Milestone…
shutterstock_148562033
January 29, 2026   Supreme Ventures Limited (SVL) has advised that on January 28, 2026, a Director purchased 319,424 SVL shares and a relat…